Management of agitation and convulsions in hepatic encephalopathy

Indian Journal of Gastroenterology

Volumn 22, Issue SUPPL. 2, 2003, Pages

  Prabhakar, S ^a   Bhatia, R ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Anticonvulsant therapy; Seizures

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAMAZEPINE; CLOZAPINE; DOPAMINE RECEPTOR BLOCKING AGENT; DROPERIDOL; FELBAMATE; GABAPENTIN; HALOPERIDOL; LAMOTRIGINE; LIDOCAINE; MIDAZOLAM; OXAZEPAM; PARALDEHYDE; PHENOBARBITAL; PHENYTOIN; PINDOLOL; PRIMIDONE; PROPRANOLOL; RISPERIDONE; THIOPENTAL; TOPIRAMATE; VALPROIC ACID;

AGITATION; ALCOHOL WITHDRAWAL; ANTICONVULSANT THERAPY; BEHAVIOR DISORDER; COMA; CONFERENCE PAPER; CONVULSION; DELIRIUM; DOSE LIVER FUNCTION RELATION; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG CLASSIFICATION; DRUG CLEARANCE; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG ELIMINATION; DRUG EXCRETION; DRUG HALF LIFE; DRUG METABOLISM; DRUG MONITORING; DRUG PROTEIN BINDING; DRUG SAFETY; DRUG TRANSFORMATION; ELECTROENCEPHALOGRAM; EPILEPTIC STATE; EXTRAPYRAMIDAL SYMPTOM; HEPATIC ENCEPHALOPATHY; HUMAN; IMMOBILIZATION; INCIDENCE; INTOXICATION; LIVER DISEASE; LIVER TOXICITY; LOW DRUG DOSE; MENTAL DISEASE; NEUROIMAGING; PORTAL HYPERTENSION; RESPIRATION DEPRESSION; SEDATION; SIDE EFFECT;

HEPATIC ENCEPHALOPATHY; HUMANS; PSYCHOMOTOR AGITATION; SEIZURES;

EID: 1442265132     PISSN: 02548860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (24)

1. Sherlock S, Dooley J. Hepatic Encephalopathy. In: Sherlock S, Dooley J, Eds. Diseases of Liver and Biliary System. London; Blackwell Science. 1997: p. 87-97.
2. Scharschmidt BF. Acute and chronic hepatic failure and hepatic encephalopathy. In: Bennett JC, Plum F, Eds. Cecil Text Book of Medicine. Philadelphia: WB Saunders. 1996: p. 797-99.
3. Albrecht J, Jons EA. Hepatic encephalopathy: molecular mechanisms underlying the clinical syndrome. J Neurol Sci 1999;170:138-46.
4. Adams RD, Victor M, Ropper AH. Acquired metabolic disorders of nervous system. In: Adams RD, Victor M, Eds. Principles of Neurology. New York: McGraw Hill. 1997: p. 1117-20.
5. Lockwood AH. Hepatic encephalopathy and other neurologic disorders associated with gastrointestinal disease. In: Aminoff MJ, Ed. Neurology and General Practice. New York: Churchill Livingstone. 1995: p. 247-58.
6. Boggs J, Waterhouse E, Delovenzo RJ. The use of antiepileptic medications in renal and liver disease. In: Wyllie E, Ed. The Treatment of Epilepsy. Principles and Practice. Baltimore: Williams and Wilkins. 2002: p. 795-810
7. Hullihan JF. Seizures in special populations. Children, the elderly and patients with co-existing medical illness. Postgrad Medicine 1997;102:165-8, 171-2, 175-6.
8. Ficker DM, Westmoreland BF, Sharbrough FW. Epileptiform abnormalities in hepatic encephalopathy. J Clin Neurophysiol 1997;14:230-4.
9. Felco FM, Wijdicks, Sharbrough FW. New onset seizures in critically ill patients. Neurology 1993;43:1042-4.
10. Delanty N, Vanugham CJ, French JA. Medical causes of seizures. Lancet 1998;352:383-90.
11. Boggs JG. Seizures in medically complex patients. Epilepsia 1997;38:S55-S59.
12. Gillmore RL. Seizures associated with non-neurologic medical conditions. In: Wyllie E, Ed. The Treatment of Epilepsy. Principles and Practice. Baltimore: Williams and Wilkins. 1997: p. 654.
13. Adams RD, Foley JM. The neurological disorder associated with liver disease. In: Merritt HH, Hare CC, Eds. Metabolic and Toxic Diseases of the Nervous System. Baltimore: Williams and Wilkins. 1953: p. 198-237.
14. Plum F, Posner JB. Multifocal, diffuse and metabolic brain diseases causing stupor and coma. In: Plum F, Posner JB, Eds. Diagnosis of Stupor and Coma. Philadelphia, PA: FA Davis. 1980: p. 222-5.
15. Ellis JA, Wendon JA, Williams R. Subclinical seizure activity and prophylactic phenytoin infusion in acute liver failure: A controlled clinical trial. Hepatology 2000;32:536-41.
16. Jordan KG. Continuous EEG and evoked potentials monitoring in the neuroscience intensive care unit. J Clin Neurophysiol 1993;10:445-75.
17. Asconope JJ, Panny JK. Use of antiepileptic drugs in the presence of liver and kidney disease: a review. Epilepsia 1982;23:565-79.
18. Messing RO, Simon RP. Seizures as a manifestation of systemic disease. Neurol Clin North Am 1986;4:573-88.
19. Holland KD. Efficacy, pharmacology, and adverse effects of antiepileptic drugs. Neurol Clin North Am 2001;19:313-47.
20. Shorvon SD. Emergency treatment of epilepsy: Acute seizures, serial seizure clusters and status epilepticus. In: Shorvon S, Ed. Handbook of Epilepsy Management. London: Blackwell Science. 2000: p. 173-94.
21. Tardiff K. Adult antisocial behaviour and criminality. In: Kaplan HI, Sadock BJ, Eds. Comprehensive Textbook of Psychiatry. Baltimore: Williams and Wilkins. 1995: p. 1629-32.
22. Resnick PJ, Scott CL. Legal issues in treating perpetrators and victims of violence. Psychiatr Clin North Am 1997;20:473-87
23. Trzepacz PT. Delirium: Advances in diagnosis, pathophysiology and treatment. Psychiatr Clin North Am 1996;19:429-48.
24. Brizer DA. Psychopharmacology and the management of violent patients. Psychiatr Clin North Am 1988;11:551-68.